Agreement Between 2 Sources of Antipsychotic Coding Before and During the COVID-19 Pandemic in Long-Term Care
J Am Med Dir Assoc
.
2023 Jun;24(6):923-925.e1.
doi: 10.1016/j.jamda.2023.03.041.
Epub 2023 Apr 21.
Authors
Jeffrey Poss
1
,
James Silvius
2
,
Matthias Hoben
3
,
Adrian Wagg
4
,
Malcolm Doupe
5
,
Peter Norton
2
,
Laurel Scott
6
,
Carole Estabrooks
7
Affiliations
1
School of Public Health Sciences, University of Waterloo, Waterloo, Canada. Electronic address: jwposs@uwaterloo.ca.
2
Department of Medicine, University of Calgary, Calgary, AB, Canada.
3
School of Health Policy and Management, Faculty of Health, York University, Toronto, ON, Canada.
4
Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
5
Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
6
Alberta Health Services, Edmonton, AB, Canada.
7
Faculty of Nursing, University of Alberta, Edmonton, AB, Canada.
PMID:
37209712
PMCID:
PMC10121135
DOI:
10.1016/j.jamda.2023.03.041
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Antipsychotic Agents* / therapeutic use
COVID-19*
Humans
Long-Term Care
Pandemics
SARS-CoV-2
Substances
Antipsychotic Agents
Grants and funding
RES0053356/CIHR/Canada